Choroidal neovascularisation and Maculopathy - from FDA reports


Maculopathy is found among people with Choroidal neovascularisation, especially for people who are male, 60+ old, take medication Lucentis and have Age-related macular degeneration. This review analyzes which people have Maculopathy with Choroidal neovascularisation. It is created by eHealthMe based on reports of 17 people who have Choroidal neovascularisation from FDA , and is updated regularly.

What to expect?

If you have Choroidal neovascularisation and Maculopathy, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who have Choroidal neovascularisation and Maculopathy

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Aug, 19, 2017

17 people who have Choroidal Neovascularisation and Maculopathy are studied.

Number of reports submitted per year:

Would you have Maculopathy when you have Choroidal neovascularisation?

Gender of people who have Choroidal Neovascularisation and experience Maculopathy *:

  • female: 41.67 %
  • male: 58.33 %

Age of people who have Choroidal Neovascularisation and experience Maculopathy *:

  • 0-1: 0.0 %
  • 2-9: 9.09 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 18.18 %
  • 60+: 72.73 %

Top co-existing conditions for these people *:

  • Macular Degeneration (1 person, 5.88%)
  • Detachment Of Retinal Pigment Epithelium (1 person, 5.88%)
  • Age-Related Macular Degeneration (1 person, 5.88%)

Most common drugs for these people *:

  • Visudyne (5 people, 29.41%)
  • Lucentis (5 people, 29.41%)
  • Zetia (2 people, 11.76%)
  • Pitavastatin Calcium (2 people, 11.76%)
  • Levofloxacin (2 people, 11.76%)

Top symptoms for these people *:

  • Visual Acuity Reduced (6 people, 35.29%)
  • Retinal Disorder (3 people, 17.65%)
  • Herpes Zoster (3 people, 17.65%)
  • Macular Hole (2 people, 11.76%)
  • Cataract (2 people, 11.76%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Maculopathy and Choroidal neovascularisation?

Expand the study to include reports from both FDA and eHealthMe

Maculopathy and Choroidal neovascularisation from FDA and eHealthMe reports

Choroidal Neovascularisation

Choroidal neovascularisation (creation of new blood vessels in vascular layer of eye) (latest reports from 1,798 Choroidal neovascularisation patients)


Maculopathy (condition or disease of the macula, the small spot in the retina where vision is keenest) has been reported by people with high blood pressure, rheumatoid arthritis, multiple sclerosis, maculopathy, osteoporosis (latest reports from 2,094 Maculopathy patients).

Browse all symptoms of Choroidal neovascularisation

a b c d e f g h i j k l m n o p q r s t u v w x y z

Could your drugs cause Maculopathy


Other conditions that could case Maculopathy


Related studies

What would happen?

Forecast new side effects and undetected conditions when you have Choroidal neovascularisation and Maculopathy.